Novavax | NVAX - Trade Creditors


Novavax reported $16.1M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Adma Biologics USD 20.52M 2M Mar/2026
Agenus USD 71.08M 11.9M Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
BioCryst Pharmaceuticals USD 10.96M 4.87M Mar/2026
Cassava Sciences USD 41.65M 4.44M Dec/2025
Geron USD 12.72M 1.46M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
MannKind USD 16.14M 7.11M Mar/2026
Merck USD 3.86B 541M Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Moderna USD 161M 156M Mar/2026
Novartis USD 4.46B 99M Dec/2025
Novavax USD 16.1M 8.48M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Sanofi EUR 22.71B 219M Mar/2026
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026